Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction COMMENT

Editorial

Open access

Andrew L. Koenig and Kory J. Lavine

JACC. Basic to translational science, Vol.6(8), pp.690-692

08/01/2021

DOI: 10.1016/j.jacbts.2021.07.009

PMID: 34466755

Files and links (1)

url

https://doi.org/10.1016/j.jacbts.2021.07.009View

Published (Version of record) Open Access

Editorial comment

Cardiac & Cardiovascular Systems

Cardiovascular System & Cardiology

Life Sciences & Biomedicine

Science & Technology

Title: Subtitle: Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction COMMENT
Creators: Andrew L. Koenig - Washington University in St. Louis
Kory J. Lavine - Washington University in St. Louis
Resource Type: Editorial
Publication Details: JACC. Basic to translational science, Vol.6(8), pp.690-692
DOI: 10.1016/j.jacbts.2021.07.009
PMID: 34466755
ISSN: 2452-302X
eISSN: 2452-302X
Publisher: Elsevier
Number of pages: 3
Grant note: Burroughs Foundation Welcome Fund Children's Discovery Institute of Washington University and St. Louis Children's Hospital R01HL138466; R01HL139714 / National Heart Lung and Blood Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) Leducq Foundation HL138466; HL139714; HL151078; AI148877 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Foundation of Barnes-Jewish Hospital
Language: English
Date published: 08/01/2021
Academic Unit: Stead Family Department of Pediatrics
Record Identifier: 9985161457102771

1 Record Views